Deferrioxamine B en es it fr

Deferrioxamine B Brand names, Deferrioxamine B Analogs

Deferrioxamine B Brand Names Mixture

  • No information avaliable

Deferrioxamine B Chemical_Formula

C20H29N3O2

Deferrioxamine B RX_link

No information avaliable

Deferrioxamine B fda sheet

Deferrioxamine B msds (material safety sheet)

Deferrioxamine_B MSDS

Deferrioxamine B Synthesis Reference

No information avaliable

Deferrioxamine B Molecular Weight

343.463 g/mol

Deferrioxamine B Melting Point

99-101oC (HCl salt)

Deferrioxamine B H2O Solubility

42 mg/L

Deferrioxamine B State

Solid

Deferrioxamine B LogP

3.588

Deferrioxamine B Dosage Forms

Ointment

Deferrioxamine B Indication

For production of local or regional anesthesia by infiltration techniques such as percutaneous injection and intravenous regional anesthesia by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks.

Deferrioxamine B Pharmacology

Dibucaine is an amide-type local anesthetic, similar to lidocaine.

Deferrioxamine B Absorption

In general, ionized forms (salts) of local anesthetics are not readily absorbed through intact skin. However, both nonionized (bases) and ionized forms of local anesthetics are readily absorbed through traumatized or abraded skin into the systemic circulation.

Deferrioxamine B side effects and Toxicity

Subcutaneous LD50 in rat is 27 mg/kg. Symptoms of overdose include convulsions, hypoxia, acidosis, bradycardia, arrhythmias and cardiac arrest.

Deferrioxamine B Patient Information

No information avaliable

Deferrioxamine B Organisms Affected

Humans and other mammals